Title: Cognitive Performance in
1Cognitive Performance in
Vitamin B12 Deficient Vegan Men with
Intermediate Hyperhomocysteinaemia
Vaughan Bell 1, Zouë Lloyd-Wright 2, Jan Møller 3,
Anne-Mette Hvas 3, Ebba Nexø 3, Virginia Ng 2,
Steven Williams 2, Tim Key 4, Tom A. B. Sanders 2
1 Cardiff University, 2 Kings College London,
3 Aarhus University Hospital, 4 Oxford University
2Aims
- Previous studies have typically worked with
- Older adults / demented patients
- Inappropriate cognitive tests (e.g. MMSE)
- We targeted low / normal B12 vegans
- Otherwise healthy, with full age range.
- Used cross-sectional / double-blind RCT
supplementation design. - Relevant and robust neuropsychological tests.
- Comprehensive structural neuroimaging.
3Sample
Vegan males, N 138
Three groups No significant differences
between groups on age, mean veganism, NART IQ
4Homocysteine
Baseline total mean 19.4 µmol/L (22.6)
SD 36.89
SD 13.38
SD 2.54
ANOVA p lt 0.0005, Pearson r -.352, p lt 0.0005
5Design
- Phase 1 Baseline assessment
- Comparison between B12 groups
- Phase 2 Double blind RCT Four groups
- 5mg/day B12 supplementation
- Tested again after 3 months
- Compared active / placebo
6Effect of Supplementation
7Cognitive Tests
- Tests were chosen to be
- Sensitive to sub-clinical and clinical deficits.
- Have known links to functional neuroanatomy.
- Well controlled (computer presented)
- And for semantic and working memory tasks
- Have varying levels of demand.
- Have clear patterns of performance in healthy
participants.
8Episodic Memory
One way ANOVA (B12 Group)
Two-way mixed ANOVA (Phase x Treatment)
- Free recall
- No effect of group (p 0.94), phase (p 0.62)
- No phase x treatment interaction (p 0.39)
- Single-probe recognition
- No effect of group (p 0.55), phase (p 0.19)
- No phase x treatment interaction (p 0.22)
9Semantic Memory
Multi-factorial sentence verification task
(Kounios Holcomb, 1992)
ALL BIRDS ARE CROWS NO VEGETABLES ARE HAMMERS
- Semantic manipulation
- High / low relatedness
- Category / exemplar order
- All / No sentence
10Semantic Memory
One way ANOVA (B12 Group)
Two-way mixed ANOVA (Phase x Treatment)
- No main effect of group (p 0.37)
- Main effect for phase (p 0.004, practice
effect) - No phase x treatment interaction (p 0.90)
- All semantic manipulations had expected effect
11Working memory
n-back task (Braver et al., 1997)
- Random letters appear on-screen one by one.
- Four conditions 0, 1, 2 and 3-back
- Participants must indicate if the letter
on-screen matches the letter n-back. - 33 targets in each condition.
- Prefrontal cortex involvement directly related to
working memory load.
12Working memory
Phase 1
13Working memory
Phase 2
14Working memory
n-back task (Braver et al., 1997)
- 3 way ANOVA treatment x phase x n-back
- Main effect for n-back (p lt 0.0005)
- No main effect for phase (p 0.092)
- No main effect for treatment (p 0.586)
- No interactions
15Neuroimaging
18 males with lt 120ng/L for 10 years, brain /
spine scans with 1.5 Telsa structural MRI (T1 /
T2 / FLAIR)
- 50 yr vegan male with dorsal spinal column
demyelination - T2 weighted MRI scan of upper thoracic area.
Nakamura and Swanson (2004)
Present study
16Neuroimaging
No evidence of brain / spinal column
neuropathology when assessed by a consultant
radiologist.
No evidence of clinical signs of B12 deficiency
(e.g. tingling, fatigue, weakness,
confusion)
17Very Low B12 Participants
- Imaging included 3 participants with very low B12
levels (8, 33 and 38 ng/L) - Cognitive tests showed no obvious deficits
18Possible explanation
Compensation from excellent cerebrovascular
function and high levels of folate
UK omnivore male mean
No main effect (p 0.78), no post-hoc differences
19Possible explanation
- e.g. low folate largely known to be linked to
poor cognition in older adults, independent of
B12, B6, homocysteine levels (Kado et al., 2005). - Although see Morris et al. (2005).
20Conclusions
- Low B12 and hyperhomocysteinanemia not
necessarily associated with - Cognitive dysfunction
- Neuropathology
- Our sample possibly protected by
- high levels of folate
- excellent cerebrovascular function